Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
644
-
Total 13F shares, excl. options
-
68M
-
Shares change
-
-1.48M
-
Total reported value, excl. options
-
$13B
-
Value change
-
-$206M
-
Put/Call ratio
-
0.96
-
Number of buys
-
346
-
Number of sells
-
-290
-
Price
-
$190.84
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q2 2020
768 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q2 2020.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 644 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68M shares
of 176M outstanding shares and own 38.73% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.92M shares), BlackRock Inc. (6.77M shares), BAILLIE GIFFORD & CO (5.97M shares), JENNISON ASSOCIATES LLC (3.67M shares), Capital World Investors (2.51M shares), JPMORGAN CHASE & CO (2.26M shares), STATE STREET CORP (1.46M shares), Bank of New York Mellon Corp (1.16M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.08M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.04M shares).
This table shows the top 644 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.